Total Voting Rights

Fidelity Special Values PLC repurchased 0 ordinary shares in March 2026 and issued 0 ordinary shares. Issued share capital as at 31 March 2026 stood at 324,348,920 ordinary shares. This is a routine DTR 5.6.1 disclosure with no change to share count or treasury status and is unlikely to affect market prices.

Analysis

For closed‑end investment vehicles, capital allocation choices are a lever to manage the discount/premium to NAV; absent aggressive deployment that lever leaves price discovery to market flows and sentiment, increasing the probability that valuation gaps persist for quarters. A 5–10% persistent discount gap on a £1bn+ trust typically equates to a 5–10% opportunity (or loss) to patient capital if mean reversion occurs within 6–12 months — conversely, a lull in repurchase activity increases the chances that discount dynamics become self‑reinforcing as retail redemption pressure and index reweighting act asymmetrically.

Second‑order beneficiaries of a restrained repurchase posture include other UK closed‑end trusts and specialist activist funds: capital seeking discount capture will rotate to trusts with explicit buyback programs, potentially compressing their discounts while leaving the index constituent wider. In parallel, the trustee/board signaling effect is non‑trivial — continued passivity raises the probability of an activist approach or a tender offer proposal within 6–18 months, especially if macro volatility elevates yield‑seeking flows into the universe.

Key catalysts to watch are NAV relative performance (quarterly), a change in dividend policy, or explicit board language on buyback capacity; each can move the discount 200–500bps within 30–90 days. Tail risks include a sudden widening in gilt yields or a material drawdown in underlying equities: either can force a structural re‑rating of closed‑end trust discounts over multiple quarters and turn a short‑dated tactical trade into a prolonged value trap.

Key Decisions for Investors

• Long FSV.L (size 2–4% portfolio): enter on persistent discount >8% to NAV or on outright oversold moves in UK small/ mid cap exposure; target 25–35% total return if discount compresses to 2–4% within 6–12 months. Protect with a 10% cash stop or hedge underlying equity beta if market volatility rises.
• Pair trade — long FSV.L / short VUKE.L (notional beta‑neutral vs FTSE exposure): run 3–12 months to isolate discount capture. Expect 15–25% relative upside if discount mean‑reverts; risk if underlying UK large caps materially outperform the trust’s NAV (use monthly rebalancing to control drift).
• Event‑driven options or TRS (12 months): buy call exposure (or TRS equivalent) sized to 3% portfolio with a 1:1 funded short of deeper OTM calls to reduce carry — asymmetric payoff if board announces buybacks/tender within 12 months. Aim for 3x downside protection vs premium paid; unwind if no catalyst within 9–12 months.
• Monitor triggers & precommit: set alerts for (a) dividend change, (b) NAV vs FTSE relative performance >200bp/quarter, (c) any board statement on repurchases/issuance. If an activist approach is announced, increase position to 5–7% with readiness to exit into tender/auction news (take 40–60% profits on announcement).